Podcast Episodes
Back to Search
Pharmaceutical Executive Daily: Why DSCSA Compliance is Only The Beginning
In today’s Pharmaceutical Executive Daily, we cover the FDA’s approval of Johnson & Johnson’s Simponi for pediatric ulcerative colitis, why DSCSA com…
9 months ago
Pharmaceutical Executive Daily: Amgen Launches New Direct-To-Consumer Platform
In today’s Pharmaceutical Executive Daily, we explore why medical AI success depends on more than algorithms, Amgen’s launch of its new direct-to-con…
9 months, 1 week ago
Pharmaceutical Executive Daily: FDA Lifts Clinical Hold on NUZ-001
In today’s Pharmaceutical Executive Daily, we cover the FDA lifting its clinical hold on Neurizon Therapeutics’ lead program Nuz-001, the agency’s ex…
9 months, 1 week ago
Pharmaceutical Executive Daily: Updated Vaccine Recommendations
Welcome to Pharmaceutical Executive Daily, your quick briefing on the top news shaping the pharmaceutical and life sciences industry. In today’s Phar…
9 months, 1 week ago
Pharmaceutical Executive Daily: FDA's new Fast-Track Review
In today’s Pharmaceutical Executive Daily, we cover the FDA’s new fast-track review program for U.S.-made generics, Novartis’ FDA approval of Rhapsid…
9 months, 1 week ago
Pharmaceutical Executive Daily: President Trump Pauses Tariff Plan
Stay informed on key pharmaceutical news, including tariff updates, FDA shutdown risks, and insights from recent cell and gene therapy reviews.
9 months, 1 week ago
Pharmaceutical Executive Daily: Novo Nordisk Resubmits BLA for Awiqli
In today’s Pharmaceutical Executive Daily, we cover Novo Nordisk’s resubmission of its BLA for Awiqli, the FDA’s approval of Kedrion’s Qivigy for pri…
9 months, 2 weeks ago
Pharmaceutical Executive Daily: September 30, 2025
In today’s Pharmaceutical Executive Daily, we cover AbbVie’s new API manufacturing site in Illinois, AstraZeneca’s plan to harmonize its global stock…
9 months, 2 weeks ago
Pharmaceutical Executive Daily: September 29, 2025
In today’s Pharmaceutical Executive Daily, we cover the impact of Novo Nordisk layoffs on its hometown in Denmark, GSK’s appointment of Luke Miels as…
9 months, 2 weeks ago
Pharmaceutical Executive Daily: September 26, 2025
In today’s Pharmaceutical Executive Daily, we cover the White House’s push for a Most Favored Nation drug pricing model, the FDA’s approval of Eli Li…
9 months, 2 weeks ago